Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Language
Document Type
Year range
1.
Computing. Archives for Informatics and Numerical Computation ; 104(6):1481-1496, 2022.
Article in English | ProQuest Central | ID: covidwho-1872437

ABSTRACT

Online social platforms or social platforms such as Twitter, Facebook and Instagram have become popular platforms for a public discussion about social topics. Recent studies show that there is a growing tendency for people to talk about COVID-19 pandemic in these online channels. The rapid growth of the infected cases by COVID-19 pandemic makes a lots of anxiety and fear among people. With the recent released of Pfizer vaccine, people start posting a lot of rumors regarding the safety concerns of the vaccine, especially among the elderly people. The aim of this study is to bring out the fact that tweets containing all pertinent details about the COVID-19 vaccine and provides an analysis and understanding of users emotions regarding the recent release of COVID-19 vaccine. This study starts with the collection of tweets related to COVID-19 vaccine and then cleaning the dataset from redundant tweets. In this study, we use Twitter API and Web Scraping techniques to obtain a sample of 50,000 tweets talking about COVID-19 vaccine.Further, The analysis of users emotions is achieved by manually labeling and classifying the tweets to either positive or negative. Then, a deep learning based model is used to train the data and classify the people opinion about COVID-19 vaccine. The experimental results illustrate that high percentage of people have shown a positive attitude towards COVID1-19 vaccine. The proposed method is validated over Twitter datasets and the results also demonstrate that use of deep learning classifier can successfully improve the accuracy of people emotions analysis with an accuracy up to 98% for training set and the accuracy for testing set is 73%.

2.
Neural Comput Appl ; 33(7): 2929-2948, 2021.
Article in English | MEDLINE | ID: covidwho-898020

ABSTRACT

Globally, many research works are going on to study the infectious nature of COVID-19 and every day we learn something new about it through the flooding of the huge data that are accumulating hourly rather than daily which instantly opens hot research avenues for artificial intelligence researchers. However, the public's concern by now is to find answers for two questions; (1) When this COVID-19 pandemic will be over? and (2) After coming to its end, will COVID-19 return again in what is known as a second rebound of the pandemic? In this work, we developed a predictive model that can estimate the expected period that the virus can be stopped and the risk of the second rebound of COVID-19 pandemic. Therefore, we have considered the SARIMA model to predict the spread of the virus on several selected countries and used it for predicting the COVID-19 pandemic life cycle and its end. The study can be applied to predict the same for other countries as the nature of the virus is the same everywhere. The proposed model investigates the statistical estimation of the slowdown period of the pandemic which is extracted based on the concept of normal distribution. The advantages of this study are that it can help governments to act and make sound decisions and plan for future so that the anxiety of the people can be minimized and prepare the mentality of people for the next phases of the pandemic. Based on the experimental results and simulation, the most striking finding is that the proposed algorithm shows the expected COVID-19 infections for the top countries of the highest number of confirmed cases will be manifested between Dec-2020 and  Apr-2021. Moreover, our study forecasts that there may be a second rebound of the pandemic in a year time if the currently taken precautions are eased completely. We have to consider the uncertain nature of the current COVID-19 pandemic and the growing inter-connected and complex world, that are ultimately demanding flexibility, robustness and resilience to cope with the unexpected future events and scenarios.

SELECTION OF CITATIONS
SEARCH DETAIL